Chitosan-modified polymeric nanoparticles for the nose-to-brain drug delivery of paroxetine: an in vitro and in vivo evaluation

Chitosan-modified PLGA nanoparticles can increase the therapeutic potential of the paroxetine drug by increasing the targeted delivery through a cellular uptake mechanism. The mucoadhesive polymers enhance drug delivery via the intranasal route.